Latest Capital Raising And Funding News

Artemis Resources has completed a $4.9 million capital raise to fund extensive drilling programs targeting gold and copper at its Carlow, Titan, and Cassowary projects in Western Australia. The funding will accelerate exploration efforts aimed at expanding mineral resources and testing new high-potential targets.

Cobram Estate Olives Limited has launched a $185 million capital raising to fund a major expansion of its vertically integrated olive oil operations in California, aiming to become the largest olive farmer in the US.

EMU NL has announced a non-renounceable entitlement offer to raise approximately $1.83 million to fund exploration at its Georgetown and Badja projects, while facing significant governance challenges ahead of a pivotal shareholder meeting.

EMU NL has announced a $1.83 million non-renounceable entitlement offer to fund exploration at its Georgetown and Badja projects, while facing potential board upheaval at an upcoming general meeting.

iTech Minerals has announced a $2 million equity raise, including a $1 million Share Purchase Plan offering shares at a 14.2% discount to fund key mineral exploration projects and working capital.

Amaero Ltd has updated its FY2026 financial guidance, forecasting revenue between A$30 million and A$35 million; a staggering 800%-900% increase year-over-year; and announced a A$50 million capital raise to expand production capacity and reduce costs.

Lincoln Minerals Limited has announced a supplementary prospectus to raise an additional $750,000 through a Follow-on Placement, responding to strong investor demand beyond its initial entitlement offer.

RLF AgTech Ltd has reported a remarkable financial turnaround in FY25, with revenues more than doubling and losses narrowing significantly, setting the stage for expansion in FY26.

Chimeric Therapeutics reported a reduced net loss of $10.43 million for FY2025, driven by cost efficiencies and strategic project reprioritisation, while making significant clinical progress in its CAR T-cell and NK cell therapy programs.

Assetora Limited reported a reduced loss of $3.35 million for FY2025 despite an 18% revenue decline, focusing on capital raising and fund growth to stabilize operations.

Skin Elements Limited reported a 13% revenue increase and a 20% reduction in net loss for FY2025, as it progresses commercial roll-out of its natural biotech products including ECO-Nurture and SuprCuvr.

IMEXHS Limited reported a $3 million net loss for the half-year ending June 2025, driven by a significant goodwill impairment, while annualised recurring revenue rose 11%. The company completed a $2.6 million capital raise to support growth amid ongoing cost optimisation and automation efforts.